Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients.

Naomi Iwasa-InoueHiroyuki NomuraFumio KataokaTatsuyuki ChiyodaTomoko YoshihamaYoshiko NankiKensuke SakaiYusuke KobayashiWataru YamagamiTohru MorisadaAkira HirasawaDaisuke Aoki

Published in: International journal of clinical oncology (2021)

Neoadjuvant dose-dense TC-bevacizumab therapy was well tolerated, and a satisfactory rate of complete resection by IDS was achieved.

Keyphrases

rectal cancer
lymph node
locally advanced
neoadjuvant chemotherapy
metastatic colorectal cancer
coronary artery bypass
randomized controlled trial
clinical trial
phase ii study
coronary artery disease
mesenchymal stem cells
percutaneous coronary intervention
chemotherapy induced